Delivery Order SPE2DB20D1100-SPE2DB24FA8C6
- Not listed
- This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,009.00 for the procurement of Olopatadine HCl 0.1% eye drops in 5 ml containers. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award, which is not designated as a set-aside contract....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $2,112.82 firm-fixed-price contract has a performance period through May 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,935.80 firm fixed-price delivery order is for the supply of Olopatadine HCl 0.1% eye drops in 5ml bottles. The contract has an ultimate completion date of September 15, 2022 and was awarded on September 14, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Olopatadine Hydrochloride 0.1% Eye Drops in 5 mL containers. The award, with a ceiling value of $2,085.00, is a Firm Fixed Price Delivery Order contract with a completion date of August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp.'s Corporate Office Division is the prime contractor for this award, which is part...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Olopatadine HCl 0.1% eye drops in 5ml vials. The firm fixed price contract, awarded by the Defense Logistics Agency (DLA), has a potential value of $1,969.92 and a period of performance through March 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will supply this pharmaceutical product to support military treatment programs and facilities. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,310.09, is for the delivery of Olopatadine HCl 0.1% eye drops in 5ml vials. The contract is a delivery order type with a firm fixed price pricing structure, and the ultimate completion date is December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.35 firm fixed price delivery order covers the procurement of OLOPATADINE HCL 0.1% EYE DROPS 5ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,583.41 firm fixed price delivery order is for the supply of Olopatadine HCL 0.1% eye drops, a branded pharmaceutical product. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to...
- This federal contract award, valued at $2,115.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine Hydrochloride 0.1% eye drops, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,382.67 firm fixed-price delivery order is for the supply of OLOPATADINE 0.1% OS 1S, a prescription eye drop medication. The contract has an ultimate completion date of April 18, 2025 and was awarded on March 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA8C6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,825.66 firm fixed price delivery order is for the supply of Olopatadine HCL 0.1% eye drops, a prescription ophthalmic medication. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and medical facilities worldwide. The IDC was awarded solely to Amerisourcebergen Drug Corp as a single award contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/19/24 |